Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

ServiceUpdated on 22 September 2026

Connected device assessment: from device data to a prioritised digital product roadmap

CEO at Airbag Studio

Ascoli Piceno, Italy

About

Most manufacturers already have a device that produces valuable data — what is missing is a clear, costed plan for turning that data into a product patients and clinicians actually use.

What we do

  • Field analysis of the device, the data it generates and the regulatory constraints that apply to it (MDR classification, software lifecycle implications, data protection).

  • Information and data architecture: what is measured, where it is stored, how it flows to app, backend and third-party systems (HL7/FHIR, national health systems, Apple Health, Google Fit).

  • Mapping of digital opportunities — patient app, clinician dashboard, remote monitoring, automation and AI components — each prioritised and paired with an estimated effort and investment range.

  • A feature map validated together with your team in a dedicated workshop, so the roadmap leaves the room already agreed.

What you get
A decision-ready document: prioritised opportunities, target architecture, regulatory implications and a phased implementation plan that can be executed by us, by your internal team, or by both.

Who it is for
Medical device manufacturers, diagnostics and life science companies that are planning a connected product, or that have one and need to decide where to invest next.

Why Airbag Studio
Italian SME, founded in 2017, specialised in digital health mobile ecosystems. Software design and development under ISO 9001 and IEC 62304. Track record with Empatica, Newronika, COSMED, Menarini Group, Amiko, Flaem, Redax, TiCare and Euleria Health.

Similar opportunities